Drug-related problem (DRP) use of oral antidiabetics and insulin in patients with diabetes mellitus type II hospitalised at RSU Royal Prima Medan
Article Sidebar
Main Article Content
Page: 1079-1085
Abstract
Diabetes mellitus is a group of metabolic disorders characterised by hyperglycemia which is the cause of death of up to 80% in low- and middle-income countries. Type 2 diabetes mellitus is the most common form of diabetes. The goals of managing type 2 diabetes mellitus therapy are to reduce the risk of microvascular and macrovascular complications, reduce mortality, and improve quality of life. Treatment of diabetes mellitus requires a long time. Problems arising from complications in diabetes mellitus will increase the difficulty in treating patients. This can potentially cause issues related to Drug Related Problems (DRP). Drug-Related Problems refers to unexpected events experienced by patients and can interfere with the success of the drug therapy given. The research method in this study was to determine the drugs to be evaluated in the form of oral antidiabetic drugs used while undergoing type 2 diabetes mellitus therapy and insulin therapy. The results showed that 26 patients experienced Drug-Related Problems or not (50%). Six patients experienced actual Drug Related Problems (10.2%). In comparison, those who experienced Potential Drug Related Problems were 24 patients (46.15%) of a total of 52 patients with type 2 diabetes mellitus who were the sample of this study. Two categories of Drug Related Problems occur, namely Drug Related Problems related to additional drug therapy with a total of 2 incidents (2.17%) and Drug Related Problems related to unwanted drug reactions (Adverse Drug Reactions) with a total of 4 incidents (7,7%).
Downloads
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
References
American Diabetes Association. 2014. Diagnosis and Classification of Diabetes Mellitus. Diabetes Care Vol 37, Supplement.
Atkinson A, Abernethy D, Daniel CE, Dedrick RL, Markey SP. 2007. Principles of Clinical Pharmacology Second Edition. USA: Elsevier Inc. p. 230.
Ayuningtyas, Maria Fea Fessy. 2010. (Skripsi) Evalusi Drug Related Problems Obat Hipoglikemik Kombinasi pada Pasien Geatri Diabetes Melitus Tipe II di Instalasi Rawat Jalan RSUP Dr. Sarditjo Yogyakarta Periode Januari- juni 2009. Yogjakarta: Fakultas Farmasi USD.
Badan Penelitian dan Pengembangan Kesehatan Dapertemen Kesehatan, Republik Indonesia. 2013. Riset Kesehatan Dasar (RISKESDAS) Laporan Nasional 2012. Jakarta : Kementrian Kesehatan RI.
Baxter, Keren. 2008. Stockley’s Drug Intecration Edisi Kedelapan. Great Britain: Pharmaceutical Press. p.1-10.
Brunner and Suddarth. 2002. Buku Ajar Keperawatan Medikal Bedah, edisi 8 volume 2. Jakarta: EGC.
Charles D. Hepler. 2003. Preventing Medication Errors and Improving DrugTherphy Outcomes New York: University of Florida
Cipolle, R.J., Strand, L.M., Morley. P.C., 1998. Pharmaceutical Care Practice. New York. Mc Graw-Hill.
Corwin, Elizabeth J. 2007. Buku Saku Patofisiologi. EGC: Jakarta.
Dapertemen Kesehatan RI. 2005. Pharmaceutical Care Untuk Penyakit Diabetes Mellitus. Jakarta : Direktorat Bina Farmasi Komunitas dan Klinik.
Dipiro, J.T., Wells, B.G., Talbert, R.L., Yee, G.C., Matzke, G.R., Posey, L.M.. 2005. Pharmacotherapy Handbook Sixth Edition. New York: Mc Graw-HillCompanies. p. 415-426.
Dipiro, JT., Wells, B.G., Schwinghammer, L.T.. 2009. Pharmacotherapy Handbook Seven Edition. New York: McGraw-Hill Companies. p. 152-156.
Dapertemen Kesehatan RI. 2005. Pharmaceutical Care Untuk Penyakit Diabetes Melitus. Jakarta : Direktorat Bina Farmasi Komunitas dan Klinik.
Depkes RI. 2013. Riset Kesehatan Dasar. Jakarta: Badan Penelitian dan pengembangan Kesehatan Kementrian Kesehatan RI. Drug Interaction Checker. 2018, May Procedures:http://reference.medscape.com/drug-interactionchecker.
Gunawan, dkk., 2007. Farmakolgi dan Terapi. Jakarta: Gaya Baru.
Hardhana B, dkk. 2012. Profil Kesehatan Indonesia. Jakarta : Kementrian Kesehatan Republik Indonesia. Hal.112.
Hongdiyano, Arnold dkk. 2014. Evaluasi Kerasionalan Pengobatan DiabetesMelitus Tipe II pada Pasien Rawat Inap di RSUP Prof. Dr. R. D. Kondou Manado Tahun 2013. Jurnal ilmiah Farmasi – UNSRAT Vol.3 No. 2 Mei 2014 ISSN 2301-2493
Huri HZ, Xin CH, Sulaiman CZ. 2014. Drug Related Problems in Patients with Benign Prostatic Hyperplasia. Hong Kong: The Chinese University of Hong Kong. p.1.
IDF. 2015. IDF Diabetes Atlas Sixth Edition. Jurnal Online [diunduh 6 Agustus 2015]. Tersedia dari: http://www.idf.org/diabetesatlas/update2014.
Istiqomatunissa. 2014. (Skripsi) Rasionalitas Obat Antidiabetes dan Evaluasi Beban bayi. Jakarta: FKIK UIN Syarif Hidayatullah Jakarta.
Kemenkes RI. 2012. Riset Kesehatan Dasar; RISKESDAS. Jakarta: BalitbangKemenkes RI.
Kemenkes RI. 2013. Riset Kesehatan Dasar; RISKESDAS. Jakarta: BalitbangKemenkes RI.
Ndaraha, Suzanna. 2014. Diabetes Melitus Tipe II dan Tatalaksanaan Terkini, Vol 27 Jakarta: Dapartemen Penyakit Dalam FKUKRIDA. Hal 11-13.
Noer, Prof. dr. H. M. Sjafoellah. 2004. Ilmu Penyakit Endokrin dan Metabolik, Jilid I. Jakarta: Balai Penerbit FKUI.
Novita, Inten. 2015. (Skripsi) Evaluasi drug Related Problem Obat Antidiabetes pada Pasien Geriatri dengan Diabetes Melitus Tipe II di Ruang Rawat Inap Rumah Sakit Umum Pelabuhan Periode Januari-Juni 2014. Jakarata: FKIK UIN Syarif Hidayatullah Jakarta.
PERKENI. 2002. Petunjuk Praktis Pengelolaan DM Tipe II. Jakarta: PB PERKENI.
Perkumpulan Endokrinologi Indonesia /PERKENI. 2006. Konsensus Pengelolaan Diabetes Mellitus tipe II di Indonesia. Jakarta: PERKENI.
PERKENI. 2011. Petunjuk Praktis Pengelolaan DM Tipe II. Semarang: PB PERKENI.
PERKENI. 2015. Konsensus Pengelolaan dan Pencegahan DM Tipe II. Jakarta: PB PERKENI.
Riset Kesehatan Dasar (Riskesdas). 2013. Pedoman Pewancara Petugas Pengumpul Data. Jakarta : Badan Litbangkes Depkes RI.
RSUP Dr. M. Djamil Padang. 2015. Panduan Praktek Klinik Standar Terapi Rumah Sakit. Padang: Pengelola RSUP DR. M. Djamil Padang.
Santosa H.J. 1998. Penggunaan Obat yang Rasional. Jakarta : Kanisius.
Siregar CPJ. Lia A. 2003. Farmasi Rumah Sakit: Teori dan Penerapan Cetakan Pertama. Jakarta: Penerbit Buku Kedokteran EGC. Hal 7-18.
Smeltzer & Bare. 2002. Buku Ajar Keperawatan Medikal Bedah Brunner &Suddart, Edisi 8 vol. 3. Jakarta : EGC.
Soegondo S.. 2009. Buku Ajar Penyakit Dalam: Insulin : Farmakoterapi pada Pengendalian Glikemia Diabetes Melitus Tipe II, Jilid III, Edisi 4, Jakarta: FK UI pp. 1884.
Strand L,M, Petter CM, Cipolle RJ, Ramsey R, Lamsam GD. 1990. Drug Related Problem : Their Structure and Function. Amerika Serikat: Dapertemen of Pharmacy Practice.
Stockley, I.H. 2008. Stockley’s Drug Interaction, Edisi Kedelapan. Great Britain: Pharmaceticeutical Press. p.1-10.
Sudoyo A.W., dkk. 2006. Buku Ajar Ilmu Penyakit Dalam. Jakarta: Dapertemen Ilmu Penyakit Dalam, Fakultas Kedokteran Indonesia.
Sunjaya, I Nyoman. 2009. Pola Konsumsi Makanan Tradisional Bali sebagai Faktor Resiko Diabetes Melitus Tipe II di Tabanan. Jurnal Skala Husada Vol. 6 No.1 hal 75-81.
Tambayong, Jan. 2000. Patofisiologi Keperawatan. Jakarta : EGC.
World Health Organization (WHO). 2012. Diabetes Mellitus Report 2012. Switzerland: World Health Organization.
World Health Organization (WHO). 2014. Diabetes Mellitus Report 2014. Switzerland: World Health Organization.
Zhang, W., Liu, H., Al-Shabrawey, M., Rojas, M., Caldwell, R.W., and Caldwell, R.B. 2012. Inflamation And Diabetic Retinal Microvascular Complication. Journal of Cardiovascular Disease Research, vol 2(2), pp. 96-103